The efficacy of antimalarial monotherapies, sulphadoxine–pyrimethamine and amodiaquine in East Africa: implications for sub‐regional policy (Q38882717)
scientific article published on October 1, 2003
Language:
(P31) (Q13442814)
(P304) 860-867
(P407) (Q1860)
(P433) 10
(P478) 8
(P577) Wednesday, October 1, 2003
(P921) (Q421072)
(Q27407)
(Q521616)
(Q411557)
(Q239569)
(P953) https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1360-2276.2003.01114.x
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1360-2276.2003.01114.x
https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1360-2276.2003.01114.x
(P1433) (Q15765747)
(P1476) "The efficacy of antimalarial monotherapies, sulphadoxine-pyrimethamine and amodiaquine in East Africa: implications for sub-regional policy" (language: en)
"The efficacy of antimalarial monotherapies, sulphadoxine–pyrimethamine and amodiaquine in East Africa: implications for sub‐regional policy" (language: en)
(P2093) East African Network for Monitoring Antimalarial Treatment (EANMAT)
(P2860) (Q39055396)
(Q34655810)
(Q30755190)
(Q41918630)
(Q40866974)
(Q34109430)
(Q38884162)
(Q41913682)
(Q39118502)
(Q40790643)
(Q38948147)
(Q44012338)
(Q41919727)
other details
description scientific article published on October 1, 2003

External Links